An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

News | Dec. 21, 2016

DoD Announces Award of New Advanced Tissue Biofabrication Manufacturing Innovation Hub in Manchester, New Hampshire

Expanding efforts focused on strengthening US-based manufacturing, the Department of Defense announced the award of a new public-private Manufacturing USA institute to Advanced Regenerative Manufacturing Institute (ARMI) today. This new institute will be the 12th Manufacturing USA institute established, with the Department of Defense now leading seven of the 12.

Headquartered in Manchester, NH, this Institute is part of continuing efforts to help revitalize American manufacturing and incentivize companies to invest in new technology development in the United States. The highly competitive process resulted in ARMI’s selection to lead the Advanced Tissue Biofabrication (ATB) Manufacturing USA Institute. The award of $80 million in federal funding will be combined with over $214 million contributed by the winning consortium, made up of state and local governments, industry, universities, community colleges, and non-profit organizations located across the country. The substantial cost matching is a reflection of the importance that the US tissue biofabrication community places on this Institute and its value to US businesses, academia, and state and local governments. The ATB institute, with founding industrial and academic partners in New Hampshire, Massachusetts, Connecticut, Ohio, Wisconsin, Minnesota, Indiana, North Carolina, Florida, Tennessee, Texas, California, Colorado, Washington, Arizona, New Jersey, Pennsylvania, New York and Maryland, will organize the current fragmented domestic capabilities in tissue biofabrication technology and better position the U.S. relative to global competition.

Biofabrication is an innovative manufacturing industry segment at the intersection of biology-related research, computer science, materials science and engineering that is creating state-of-the-art manufacturing innovations in biomaterial and cell processing, bioprinting, automation and non-destructive testing technologies for critical Department of Defense and novel commercial use. ARMI, Inc. will integrate the diverse and fragmented collection of industry practices and institutional knowledge across many disciplines (cell biology, bioengineering, materials science, analytical chemistry, robotics, modeling, and quality assurance) to realize the potential of a robust biofabrication manufacturing ecosystem. Technologies ripe for significant evolution within the ATB institute include, but are not limited to, high-throughput culture technologies, 3D biofabrication technologies, bioreactors, storage methodologies, non-destructive evaluation, real-time monitoring/sensing, and detection technologies.

ATB joins the Manufacturing USA institute network which is a bipartisan program that brings together industry, academia, and government to co-invest in the development of world-leading manufacturing technologies and capabilities. Each Manufacturing USA institute focuses on a technology area critical to future competitiveness—such as 3D printing, integrated photonics, or smart sensors. Across the Manufacturing USA institutes, the Federal government has committed $860 million, which has been matched by $1.8 billion in non-Federal investment. Together, the Manufacturing USA institutes are already enhancing U.S. competitiveness in advanced manufacturing—from helping Youngstown, OH attract over $90 million in new manufacturing investments to its region and train 14,000 workers in the fundamentals of 3D printing for businesses, to supporting companies like X-FAB in Lubbock, TX upgrade to cost-competitive, next-generation semiconductors and sustain hundreds of jobs.

The ATB Manufacturing USA institute includes:

  • 47 industrial partners, including Abbott, Autodesk, Becton Dickinson, Celularity, DEKA Research & Development, GenCure, Humacyte, Lonza, Medtronic, Rockwell Automation, and United Therapeutics.
  • 26 academic and academically affiliated partners, including Arizona State University, Boston University, Cedars-Sinai Medical Center, Dartmouth College, Harvard University, Massachusetts Institute of Technology, Rutgers, Stanford University, the University of Florida, the University of Minnesota, the University of New Hampshire, Worcester Polytechnic Institute, and Yale University.
  • 14 government and nonprofit partners, including FIRST, the State of New Hampshire, and Manufacturing Extension Partnerships in multiple states.


For more information regarding this program overall and this institute in particular, visit the website at